Navigation Links
Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets
Date:8/21/2014

tumors for malignancy, using an innovative algorithmic approach. As the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, OVA1 represents a new class of software-based diagnostics. For additional information, including published clinical trials, visit www.vermillion.com.

About ASPiRA LABS
ASPiRA LABS is an innovative diagnostic services laboratory founded by Vermillion, Inc., a leader in women's health diagnostics. The laboratory's goal is to provide high quality, innovative testing for women to help address unmet women's health needs. ASPiRA LABS' specialized services are grounded in evidence-based medicine, while providing access to novel biomarker diagnostic tools designed to help health care professionals offer the most precise diagnoses and treatment guidance for their patients. To learn more about ASPiRA LABS, visit www.aspiralab.com.

Investor Relations Contact:
Eric Schoen
Vice President, Finance and Chief Accounting Officer
Tel 512-519-0424
eschoen@vermillion.com


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vermillion Reports Second Quarter 2014 Results
2. Vermillion Announces Additions to Commercial Management Team
3. Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014
4. Vermillion Completes $17.6 Million Warrant Exercise
5. Vermillion Appoints Marian E. Sacco as SVP of Sales and Marketing and Chief Commercial Officer
6. Vermillion Reports Third Quarter 2013 Results
7. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions OVA1 Test in Presurgical Detection of Early-Stage Ovarian Cancer
8. American Journal of Obstetrics & Gynecology Publishes New Clinical Study Showing Positive Performance of Vermillions Ovarian Cancer Test, OVA1
9. Vermillion Sets Third Quarter 2013 Conference Call for Thursday, November 14, 2013
10. Vermillion Appoints Dr. Eric Varma to its Board of Directors
11. Vermillion Supports First World Ovarian Cancer Day and Effort to Raise Awareness of the Need for Better Diagnosis and Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... THE WOODLANDS, Texas , Nov. 26, 2014 ... LXRX ) today announced the completion of previously ... of $280.0 million.  After fees and estimated offering ... million from the transactions.  The transactions consisted of: ... shares of common stock, pursuant to a registration ...
(Date:11/26/2014)... -- Investor-Edge has initiated coverage on the following ... PLC (NASDAQ: HZNP ), Endocyte Inc. (NASDAQ: ... ), and Theravance Inc. (NASDAQ: THRX ). Free ... http://investor-edge.com/register . On Tuesday, November 25, 2014, the ... Industrial Average edged 0.02% lower, to finish the day at ...
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
Breaking Medicine Technology:Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
(Date:11/26/2014)... Dr. Rod J. Rohrich, ... in the Department of Plastic Surgery at UT ... fat grafting, and modern lift-and-fill facelifts before colleagues ... held by the American Society of Plastic Surgeons ... facial structure were explored in detail during Dr. ...
(Date:11/26/2014)... Alex Kramer HealthDay ... People with rheumatoid arthritis may be more likely to achieve ... new research. The study found that those who were ... Being underweight also lowered the odds of remission. "Medication ... population," said Dr. Susan Goodman, the study,s lead author and ...
(Date:11/26/2014)... Amy Norton HealthDay Reporter ... people have long believed their dogs understand what they,re saying, ... emotion of words in a human-like way. Past research ... speech -- including the actual content and the emotional tone, ... give a deeper insight into the canine brain, according to ...
(Date:11/26/2014)... Even after they,re cleared to play following a concussion, ... suggests they may not be fully recovered, a new ... may be symptom-free and cleared by MLB [Major League ... of concussion on the complex motor skills required for ... Dr. Jeffrey Bazarian, an associate professor of emergency medicine ...
(Date:11/26/2014)... (HealthDay News) -- More than half of Americans with ... memory skills, a new study suggests. As ... 1.8 million Americans over the age of 70 with ... [mental] abilities," study author Dr. Vikas Kotagal, of the ... in a journal news release. The finding is ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3Health News:Your Dog Really Is Listening to You 2Health News:Your Dog Really Is Listening to You 3Health News:Harm From Baseball Concussions May Linger, Study Finds 2Health News:Too Few Americans Undergo Dementia Screening 2
... Respondents, Lives Significantly Impacted After Breaking a BoneSpecial ... Encourage Women to Make Bone Health a Priority ... The Know My Bones Council today ... which found that one-out-of-five women with postmenopausal osteoporosis ...
... Inc., the global leader in acute ischemic stroke intervention, ... its Merci Registry, a real-world, international, post-market study of ... has enrolled patients from over 30 sites worldwide and ... largest repository of data on mechanical intervention in acute ...
... MONICA, Calif., May 14 Cord Blood America, Inc. (OTC ... company ( http://www.cordblood-america.com ) focused ... families nationwide and internationally, said today it has received a ... its own state-of-the-art laboratory for the storage of multiple stem ...
... reproductive endocrinologist Richard Sherbahn, MD, at the Advanced Fertility Center of ... more eggs retrieved -- but not a correspondingly higher rate of ... ... (PRWeb) May 14, 2009 -- Infertility specialist Richard Sherbahn, MD ...
... MEDITECH and other HIT solutions can use CPMRC,s interdisciplinary clinical content ... ... MI (Vocus) May 14, 2009 -- CPM Resource Center (CPMRC) ... provide small- and medium-sized hospitals with next-generation nursing and interdisciplinary documentation ...
... week, Cimzia(R) (certolizumab pegol), the only pegylated anti-TNF, ... patients suffering from moderately to severely active rheumatoid ... experienced rapid and significant improvements in signs and ... week one, and sustained at week 24 and ...
Cached Medicine News:Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 2Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 3Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 4Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 5Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 6Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 7Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 8Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 9Health News:Concentric Medical Announces Enrollment Milestone for Merci Registry 2Health News:Concentric Medical Announces Enrollment Milestone for Merci Registry 3Health News:Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory 2Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 2Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 3Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 4Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 2Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 3Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 4Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 2Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 3Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 4Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 5Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 6Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 7Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 8Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 9Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 10
... testing feature single-well ANA screen and ENA ... tests including dsDNA, and 6 individual ENA ... Scl-70 and Jo-1. In addition, our autoimmune ... products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, ...
... autoimmune testing feature single-well ANA screen and ... reflex tests including dsDNA, and 6 individual ... (La), Scl-70 and Jo-1. In addition, our ... of products for Cardiolipins (IgA, IgG, IgM), ...
... testing feature single-well ANA screen and ENA ... tests including dsDNA, and 6 individual ENA ... Scl-70 and Jo-1. In addition, our autoimmune ... products for Cardiolipins (IgA, IgG, IgM), Thyroglobulin, ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: